Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for ...

Retrieved on: 2020-11-30 06:56:15

Tags for this article:

Branches of biology

Lewy body dementia

Biology

Neurological disorders

Neurodegenerative disorders

Geriatrics

Psychiatric diagnosis

Synucleinopathy

Lewy body

Proteopathy

Multiple system atrophy

Alpha-synuclein

Eisai Co. Ltd.

Wren Therapeutics Ltd.

United Kingdom

Click the tags to see associated articles and topics

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for .... View article details on HISWAI: https://www.oaoa.com/news/business/eisai-and-wren-therapeutics-enter-into-research-collaboration-agreement-for-drug-discovery-for-synucleinopathies/article_f06d432b-6139-55f8-ae65-779251d01832.html

Excerpt

As a global pharmaceutical company, our mission extends to patients ... BIOTECHNOLOGY <b>HEALTH SCIENCE PHARMACEUTICAL RESEARCH</b>.

Article found on: www.oaoa.com

View Original Article